ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 138 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,461,588 | +3.0% | 57,205 | +15.6% | 0.01% | 0.0% |
Q2 2023 | $1,419,488 | +34.0% | 49,494 | +12.0% | 0.01% | +25.0% |
Q1 2023 | $1,059,594 | +73.0% | 44,205 | +22.4% | 0.00% | +300.0% |
Q4 2022 | $612,612 | +45.5% | 36,121 | +27.3% | 0.00% | 0.0% |
Q3 2022 | $421,000 | -15.1% | 28,382 | -9.9% | 0.00% | 0.0% |
Q2 2022 | $496,000 | -33.2% | 31,496 | +57.0% | 0.00% | 0.0% |
Q4 2021 | $742,000 | +183.2% | 20,059 | +158.7% | 0.00% | – |
Q2 2021 | $262,000 | -75.8% | 7,754 | -70.4% | 0.00% | -100.0% |
Q1 2021 | $1,082,000 | +45.4% | 26,206 | +52.8% | 0.00% | +100.0% |
Q4 2020 | $744,000 | -16.5% | 17,149 | -17.4% | 0.00% | -66.7% |
Q3 2020 | $891,000 | +4.2% | 20,762 | +13.5% | 0.00% | -25.0% |
Q2 2020 | $855,000 | +232.7% | 18,298 | -3.4% | 0.00% | +100.0% |
Q1 2020 | $257,000 | -24.4% | 18,945 | -39.4% | 0.00% | 0.0% |
Q4 2019 | $340,000 | +125.2% | 31,284 | +112.2% | 0.00% | +100.0% |
Q3 2019 | $151,000 | +15000.0% | 14,740 | +10136.1% | 0.00% | – |
Q2 2019 | $1,000 | – | 144 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
Diametric Capital, LP | 26,130 | $667,621 | 0.28% |